Detalhe da pesquisa
1.
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Int J Mol Sci
; 24(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38139339
2.
Rationale for combined therapies in severe-to-critical COVID-19 patients.
Front Immunol
; 14: 1232472, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767093
3.
Stemness of Human Pluripotent Cells: Hypoxia-Like Response Induced by Low Nitric Oxide.
Antioxidants (Basel)
; 10(9)2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34573040
4.
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Trials
; 22(1): 595, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488845
5.
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming.
Front Immunol
; 11: 609961, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33633730
6.
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
Front Immunol
; 11: 2029, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983148
7.
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
EClinicalMedicine
; 25: 100454, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32838232
8.
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
Front Immunol
; 10: 1151, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231366